2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

A modified Delphi panel to establish a threshold of meaningful progression on MDS-UPDRS Part III

D. Trundell, L. Barrett, R. Rogers, E. Davies, S. Zanigni, N. Pross, G. Pagano, T. Nikolcheva, S. Cano (Welwyn Garden City, United Kingdom)
A motor-cognitive intervention impacts daily-living gait and activity in Parkinson’s disease fallers differently than a motor intervention: analysis using a machine learning approach

K. Cohavi, S. Del Din, E. Gazit, E. Pelosin, L. Avanzino, N. Nieuwboer, B. Bloem, A. Cereatti, U. Croce, L. Rochester, N. Giladi, J. Hausdorff, A. Mirelman (Tel Aviv Yafo, Israel)
A mouse model to test the cortical pathogenic theory of Parkinson’s disease

M. Moreno-Gómez, D. Humanes-Valera, J. Pardo-Valencia, N. Mercado-García, B. Pro-Sánchez, A. Revuelto-González, T. Balzano, J. Blesa, A. Bortolozzi, J A. Obeso, G. Foffani (Móstoles, Spain)
A Narrative Review of Literature on Exercise Therapy and Cognitive Impairment in Individuals with Parkinson’s Disease: The Role of Epigenetics as a Mediator.

T. Adeniji, S. Olsen, N. Signal, J. Adeleke (Akoda-Ede, Nigeria)
A novel alpha-synuclein gene (SNCA) missense variant in an Austrian familiy with atypical neuropathological features

C. Brücke, M. Zech, T. Outeiro, E. Gelpi, A. Zimprich (VIenna, Austria)
A novel compound heterozygous PANK2 gene mutation in a South- Asian sexagenarian with atypical PKAN

K. Pillai, B. Maramattom, S. Grover, A. Kishore (Kochi, India)
A Novel Mutation of GCH1 Gene in a Case of Dopa-responsive Dystonia with Oculogyric Crises

T. Kim, D. Yoo, TB. Ahn (Seoul, Republic of Korea)
A Novel Parkinson Shoe: A potential treatment of Unresponsive Freezing of Gait in Parkinson’s Disease Patients

W. Phuenpathom, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)
A novel platform for home-based, remotely supervised, transcranial direct current stimulation treatment and assessment for Cerebellar ataxia: A randomized, double-blind, sham-controlled, crossover, feasibility study

N. Inbar, M. Abo-Said, P. Ponger, S. Frenkel-Toledo, M. Brozgol, Z. Hausdorff, Z. Yekutieli, D. Gershman, A. Hilel, A. Ezra, S. Springer, T. Gurevich (Tel Aviv, Israel)
A novel RFC1 repeat motif (ACGGG) in a patient with cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS)

M. Thomsen, M. Borsche, F. Hinrichs, C. Helmchen, N. Brueggemann, K. Lohmann (Luebeck, Germany)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z